Lipum to participate in the following upcoming events and meetings

Lipum AB (publ), a clinical stage biopharmaceutical company developing the drug candidate SOL-116 focused on chronic inflammatory diseases, today announced its participation in the following upcoming events during the autumn of 2024.

NLSDays | 18-19 September | Malmö

BioEurope | 4-6 November | Stockholm

Redeye Autoinflammatory day | 20 November | Stockholm

BioStockSummit | 20-21 November| Lund

"These meetings provide a good opportunity for us to present and discuss our progress and results from our first clinical phase 1 study, to share our ongoing plans as well as presenting key milestones and triggers with investors and partners" says CEO Ola Sandborgh.

Datum 2024-08-15, kl 08:30
Källa MFN
100% cashback på aktiecourtage! Handla aktier på eToro och få tillbaka 100% av ditt courtage i 3 månader. Hur? Registrera dig här nu direkt för att ta del av erbjudandet.
Cashback är begränsad till högst $100. Värdet på dina investeringar kan gå upp eller ner. Du riskerar ditt kapital.